The Selection of Aptamers Specific for Membrane Molecular Targets

Overview

Journal Cell Mol Biol Lett

Publisher Biomed Central

Specialties Biochemistry
Cell Biology
Molecular Biology

Date 2010 Jun 30

PMID 20585890

Citations 14

Authors

Teresa Janas

Tadeusz Janas

Affiliations

Soon will be listed here.

Abstract

A growing number of RNA aptamers have been selected experimentally using the SELEX combinatorial approach, and these aptamers have several advantages over monoclonal protein antibodies or peptides with respect to their applications in medicine and nanobiotechnology. Relatively few successful selections have been reported for membrane molecular targets, in contrast to the situation with non-membrane molecular targets. This review compares the procedures and techniques used in selections against membrane proteins and membrane lipids. In the case of membrane proteins, the selections were performed against soluble protein fragments, detergent-membrane protein mixed micelles, whole cells, vesicles derived from cellular membranes, and enveloped viruses. Liposomes were used as an experimental system for the selection of aptamers against membrane lipids. RNA structure-dependent aptamer binding for rafts in lipid vesicles was reported. Based on the selected aptamers against DOPC and the amino acid tryptophan, a specific passive membrane transporter composed of RNA was constructed. The determination of the selectivity of aptamers appears to be a crucial step in a selection, but has rarely been fully investigated. The selections, which use whole cells or vesicles derived from membranes, can yield aptamers not only against proteins but also against membrane lipids.

Citing Articles

Aptamer-Based Imaging of Polyisoprenoids in the Malaria Parasite.

Zimbres F, Merino E, Butschek G, Butler J, Duconge F, Cassera M Molecules. 2024; 29(1).

PMID: 38202761 PMC: 10780415. DOI: 10.3390/molecules29010178.

Emerging roles of extracellular vesicle-associated non-coding RNAs in hypoxia: Insights from cancer, myocardial infarction and ischemic stroke.

Hermann D, Xin W, Bahr M, Giebel B, Doeppner T Theranostics. 2022; 12(13):5776-5802.

PMID: 35966580 PMC: 9373807. DOI: 10.7150/thno.73931.

Binding of RNA Aptamers to Membrane Lipid Rafts: Implications for Exosomal miRNAs Transfer from Cancer to Immune Cells.

Janas T, Janas P, Sapon K, Janas T Int J Mol Sci. 2020; 21(22).

PMID: 33198080 PMC: 7697632. DOI: 10.3390/ijms21228503.

Aptasensors for viral diagnostics.

van den Kieboom C, van der Beek S, Meszaros T, Gyurcsanyi R, Ferwerda G, de Jonge M Trends Analyt Chem. 2020; 74:58-67.

PMID: 32287539 PMC: 7112930. DOI: 10.1016/j.trac.2015.05.012.

Exosomal miRNAs: novel players in viral infection.

Nahand J, Mahjoubin-Tehran M, Moghoofei M, Pourhanifeh M, Mirzaei H, Asemi Z Epigenomics. 2020; 12(4):353-370.

PMID: 32093516 PMC: 7713899. DOI: 10.2217/epi-2019-0192.

References

Vlassov A, Khvorova A, Yarus M . Binding and disruption of phospholipid bilayers by supramolecular RNA complexes. Proc Natl Acad Sci U S A. 2001; 98(14):7706-11. PMC: 35406. DOI: 10.1073/pnas.141041098. View

Connell G, Illangesekare M, Yarus M . Three small ribooligonucleotides with specific arginine sites. Biochemistry. 1993; 32(21):5497-502. DOI: 10.1021/bi00072a002. View

Berezovski M, Lechmann M, Musheev M, Mak T, Krylov S . Aptamer-facilitated biomarker discovery (AptaBiD). J Am Chem Soc. 2008; 130(28):9137-43. DOI: 10.1021/ja801951p. View

Mallikaratchy P, Tang Z, Kwame S, Meng L, Shangguan D, Tan W . Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol Cell Proteomics. 2007; 6(12):2230-8. DOI: 10.1074/mcp.M700026-MCP200. View

Morris K, Jensen K, Julin C, Weil M, Gold L . High affinity ligands from in vitro selection: complex targets. Proc Natl Acad Sci U S A. 1998; 95(6):2902-7. PMC: 19667. DOI: 10.1073/pnas.95.6.2902. View

Joshi R, Janagama H, Dwivedi H, Senthil Kumar T, Jaykus L, Schefers J . Selection, characterization, and application of DNA aptamers for the capture and detection of Salmonella enterica serovars. Mol Cell Probes. 2008; 23(1):20-8. DOI: 10.1016/j.mcp.2008.10.006. View

Illangasekare M, Yarus M . Phenylalanine-binding RNAs and genetic code evolution. J Mol Evol. 2002; 54(3):298-311. DOI: 10.1007/s00239-001-0045-6. View

Li N, Ebright J, Stovall G, Chen X, Nguyen H, Singh A . Technical and biological issues relevant to cell typing with aptamers. J Proteome Res. 2009; 8(5):2438-48. DOI: 10.1021/pr801048z. View

Brockstedt U, Uzarowska A, Montpetit A, Pfau W, Labuda D . In vitro evolution of RNA aptamers recognizing carcinogenic aromatic amines. Biochem Biophys Res Commun. 2004; 313(4):1004-8. DOI: 10.1016/j.bbrc.2003.12.030. View

10.

Sussman D, Nix J, Wilson C . The structural basis for molecular recognition by the vitamin B 12 RNA aptamer. Nat Struct Biol. 2000; 7(1):53-7. DOI: 10.1038/71253. View

11.

Zimmermann G, Jenison R, Wick C, Simorre J, Pardi A . Interlocking structural motifs mediate molecular discrimination by a theophylline-binding RNA. Nat Struct Biol. 1997; 4(8):644-9. DOI: 10.1038/nsb0897-644. View

12.

Gopinath S, Misono T, Kawasaki K, Mizuno T, Imai M, Odagiri T . An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion. J Gen Virol. 2006; 87(Pt 3):479-487. DOI: 10.1099/vir.0.81508-0. View

13.

Janas T, Widmann J, Knight R, Yarus M . Simple, recurring RNA binding sites for L-arginine. RNA. 2010; 16(4):805-16. PMC: 2844627. DOI: 10.1261/rna.1979410. View

14.

Shangguan D, Li Y, Tang Z, Cao Z, Chen H, Mallikaratchy P . Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A. 2006; 103(32):11838-43. PMC: 1567664. DOI: 10.1073/pnas.0602615103. View

15.

Majerfeld I, Yarus M . Isoleucine:RNA sites with associated coding sequences. RNA. 1998; 4(4):471-8. PMC: 1369632. View

16.

Shangguan D, Cao Z, Meng L, Mallikaratchy P, Sefah K, Wang H . Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J Proteome Res. 2008; 7(5):2133-9. PMC: 2749249. DOI: 10.1021/pr700894d. View

17.

Hicke B, Marion C, Chang Y, Gould T, Lynott C, Parma D . Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem. 2001; 276(52):48644-54. DOI: 10.1074/jbc.M104651200. View

18.

Majerfeld I, Yarus M . An RNA pocket for an aliphatic hydrophobe. Nat Struct Biol. 1994; 1(5):287-92. DOI: 10.1038/nsb0594-287. View

19.

Shamah S, Healy J, Cload S . Complex target SELEX. Acc Chem Res. 2008; 41(1):130-8. DOI: 10.1021/ar700142z. View

20.

Betat H, Vogel S, Struhalla M, Forster H, Famulok M, Welzel P . Aptamers that recognize the lipid moiety of the antibiotic moenomycin A. Biol Chem. 2003; 384(10-11):1497-500. DOI: 10.1515/BC.2003.165. View